What Is MTD on a Urine Drug Test?

MTD is the standard abbreviation for methadone on a urine drug test. When you see “MTD” on a drug screening panel or results sheet, it means the test is checking for the presence of methadone or its metabolites. Methadone has its own dedicated panel slot because it is chemically distinct from other opioids and does not reliably trigger a positive on a general opiate screen. The science behind the test, and the reasons it sometimes produces misleading results, gets more interesting the closer you look.

Why Methadone Gets Its Own Test Line

Standard urine drug screens use immunoassay technology, which relies on antibodies designed to bind to a particular drug or a family of structurally similar drugs. The general “opiates” line on a drug test (often labeled OPI or MOR) is built around the morphine molecule and catches drugs whose shape resembles it, like codeine and heroin. Methadone, however, is a synthetic opioid with a very different molecular structure. It does not cross-react well with morphine-targeted antibodies, so it needs its own dedicated immunoassay. That is why a standard panel might read something like “AMP / BZO / COC / MTD / OPI / THC,” with MTD sitting right alongside the others as a separate line item.

The typical screening cutoff for a positive MTD result is 300 nanograms per milliliter. If the immunoassay detects methadone or methadone-like compounds at or above that level, the test reports as positive. Because immunoassays cast a somewhat wide net, a positive screening result is usually followed by a confirmatory test using more precise methods like gas chromatography-mass spectrometry. The confirmation step can distinguish methadone itself from substances that merely resemble it.

EDDP and Why the Metabolite Matters

Many drug testing programs do not just look for methadone; they also test for EDDP, which stands for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine. EDDP is the primary metabolite the liver produces when it breaks down methadone. Testing for EDDP alongside methadone serves a very specific purpose in methadone maintenance treatment programs: it helps distinguish someone who actually swallowed and metabolized their dose from someone who added methadone directly to the urine sample to fake compliance.

If a patient’s urine contains methadone but no EDDP, it raises a red flag. It could suggest that methadone was placed directly into the sample rather than ingested and processed by the body. In practice, though, this scenario is uncommon. A large analysis of over 1,500 urine samples from Norwegian prisons found that specimens testing positive for methadone but negative for EDDP were extremely rare, accounting for only about 0.3% of cases.¹ So in the vast majority of legitimate dosing situations, EDDP shows up alongside methadone.

The ratio between methadone and EDDP in a urine sample (sometimes called the metabolic ratio) can also tell clinicians something about how well the liver is processing the drug. A ratio that shifts in unexpected directions can signal liver problems, as discussed further below.

What Can Cause a False-Positive MTD Result

One of the more frustrating aspects of the MTD immunoassay is that certain medications can trigger a positive even though the person has never taken methadone. The antibodies in the test are designed to bind to methadone’s molecular shape, but other compounds share enough structural similarity to fool them. Several documented culprits include:

Quetiapine: This atypical antipsychotic (brand name Seroquel) has been reported to cause false-positive methadone results because its structure resembles methadone closely enough to cross-react with the assay.
Diphenhydramine: The active ingredient in Benadryl and many over-the-counter sleep aids has been documented to cause false-positive methadone results at doses of 100 to 200 mg.
Doxylamine: Another antihistamine found in products like NyQuil and Unisom, doxylamine intoxication has been associated with false-positive methadone readings.
Chlorpromazine and thioridazine: These older antipsychotics can also trigger false methadone positives.

These cross-reactions are well-documented in pharmacy and toxicology literature.² If you are taking any of these medications and face an unexpected positive MTD result, the confirmatory test should clear things up. Gas chromatography-mass spectrometry can tell methadone apart from quetiapine or diphenhydramine with high accuracy. This is why requesting confirmation testing is so important when a positive screening result does not match the clinical picture.

How Urine pH Changes the Numbers

The amount of methadone that shows up in your urine is not just a straightforward reflection of how much you took. Urine pH plays a surprisingly large role. Methadone is a basic (alkaline) compound, and the kidneys handle basic drugs differently depending on how acidic or alkaline the urine is at the time.

When urine is acidic, methadone becomes ionized (electrically charged) after being filtered into the kidney tubules, which prevents it from being reabsorbed back into the blood. The result is that more methadone gets flushed out in the urine. Research has shown that acidic urine can produce roughly a three-fold increase in the kidney’s clearance of methadone compared to alkaline urine.³ A separate study found that the plasma half-life of methadone, the time it takes for blood levels to drop by half, was about 19.5 hours with acidic urine and stretched to roughly 42 hours with alkaline urine.⁴

What does this mean in practice? Two people on the same methadone dose can produce very different urine concentrations. Someone with more acidic urine might show higher urinary methadone levels, while someone with alkaline urine might show lower levels that could potentially drop below the test’s cutoff, creating the appearance of a missed dose. The Norwegian prison study also confirmed a strong correlation between urine pH and methadone concentration, with more methadone appearing at lower pH values.¹ Diet, medications like antacids, certain medical conditions, and even hydration levels can all shift urine pH enough to affect results.

Genetics and How Quickly You Clear Methadone

Your genetic makeup influences how fast your liver processes methadone, which in turn affects how much of the drug and its metabolite EDDP end up in your urine. The main enzyme responsible for breaking down methadone is called CYP2B6, and the gene encoding it comes in several variants.

People who carry the CYP2B6*6 variant are slower metabolizers. Research has found that individuals with two copies of this variant (homozygous *6/*6) had roughly 45% lower clearance of one form of methadone and about 30% lower clearance of the other form, compared to those with the standard version of the gene.⁵ On the other end of the spectrum, carriers of the CYP2B6*4 variant metabolize methadone much faster, with clearance rates three to four times greater than those with the standard gene.⁵

A separate study confirmed that CYP2B6 genotype was the key genetic driver, showing that people homozygous for the *6 allele had about double the trough plasma levels of one methadone form compared to those without the variant.⁶ The same study found that genotypes for other metabolizing enzymes, CYP2C9 and CYP2C19, did not meaningfully affect methadone levels.

For the person taking a drug test, this matters because slow metabolizers tend to accumulate more methadone in their blood and may produce urine samples with different methadone-to-EDDP ratios than rapid metabolizers. A clinician who does not account for genetic variability might misinterpret an unusual ratio as non-compliance or diversion when it actually reflects the patient’s biology. The CYP2B6*6 variant is more common in people of African descent, which also contributed to lower methadone clearance observed in African-American participants in one study.⁵ Population pharmacokinetic modeling has confirmed that weight and CYP2B6 genotype are among the most important factors influencing how the body handles methadone.⁷

When Liver Problems Change the Results

Because methadone is primarily broken down in the liver, any damage to that organ can alter what shows up in a urine test. People on methadone maintenance treatment frequently have hepatitis C or other liver conditions, which makes this a common clinical concern rather than an obscure edge case.

Research has found a significant association between markers of liver damage and a decrease in both urine and plasma EDDP concentration. The explanation is straightforward: a damaged liver has less capacity to convert methadone into EDDP. The shift in the metabolic ratio appears to come primarily from lower overall EDDP production rather than higher methadone levels.⁸ This is an important nuance: a urine sample with relatively high methadone and low EDDP might look suspicious to someone checking for diversion, but it might actually reflect a struggling liver doing its best to metabolize the drug.

This finding has practical implications for dose adjustment too. If a clinician sees changes in the metabolic ratio alongside elevated liver enzyme markers, that combination suggests the patient’s liver function has declined, and the methadone dose may need to be revisited. The urine test results become a clinical tool rather than simply a compliance check.

How Reliable Is Urine Testing in Methadone Programs

Methadone maintenance treatment programs rely heavily on urine drug testing to monitor whether patients are taking their prescribed doses and staying away from illicit substances. But the evidence suggests these programs should be more cautious about how much weight they give to urine results.

A detailed analysis of testing schedules in methadone clinics concluded that for patients attending the clinic daily, any practical testing schedule could only reliably detect people who were using heroin or other illicit drugs very frequently, essentially daily. For patients with take-home privileges (who do not come to the clinic every day), no testing schedule could effectively detect either skipped doses or illicit drug use.⁹ The researchers warned that some programs, as measured by urine test results, may appear more successful than they actually are.

This does not mean urine testing is useless; rather, it highlights a gap between what clinics expect from testing and what it can deliver. A patient who uses illicit opioids occasionally (say, once a week) has a reasonable chance of going undetected by random or even scheduled testing. Similarly, a patient who diverts or skips some take-home doses can produce plausible-looking results on the days they do provide a sample. The test captures a snapshot of a narrow window, roughly one to three days for methadone depending on the dose and the individual’s metabolism.

What to Do If Your MTD Result Seems Wrong

Given everything that can influence the MTD line on a drug test, there are several situations where a result might not reflect reality. If you are prescribed quetiapine, diphenhydramine at higher doses, or certain other medications, a false positive is a real possibility and the confirmatory test should resolve it. If you are on methadone maintenance and a test comes back unexpectedly negative, factors like alkaline urine, rapid metabolism due to your genetics, or the timing of the sample relative to your last dose could be responsible.

You are well within your rights to ask for a confirmation test rather than accepting a screening result at face value. Immunoassay screening is a first pass, not a final answer. Clinics, employers, and criminal justice systems that rely solely on immunoassay without confirmation testing are making decisions on incomplete information. If you are in a treatment program and your metabolic ratio seems off, raising the possibility of liver function changes or genetic differences with your provider is reasonable, especially if you are taking your doses as prescribed and the numbers still look unusual.

Medications That Affect Methadone Metabolism Without Showing Up on the Panel

Beyond the false-positive issue, there is a category of drug interactions that can alter your MTD results indirectly. Because methadone is processed primarily by CYP2B6 and to a lesser extent by other liver enzymes, medications that speed up or slow down those enzymes change how fast your body clears methadone. Drugs that induce (speed up) CYP enzymes, like certain anticonvulsants, some HIV medications, and rifampin (a tuberculosis antibiotic), can dramatically increase methadone clearance. The practical result is that a patient on a stable methadone dose who starts one of these medications might see their urine methadone levels drop, potentially producing an unexpectedly negative or low test result.

The reverse also occurs. Medications that inhibit (slow down) the relevant enzymes can cause methadone to accumulate, raising both blood levels and potentially shifting the metabolic ratio in urine. These interactions do not produce a false positive or false negative in the strictest sense; the methadone is genuinely there, and the amounts measured are accurate. But they can create a misleading picture of compliance or dosing if the treating clinician is not aware of all the patient’s medications. This is one of the strongest arguments for interpreting urine drug test results in the context of a patient’s full medication list, not in isolation.

How Long Methadone Stays Detectable

Methadone is known for its long half-life, which is part of what makes it useful for maintenance therapy: a single daily dose can keep withdrawal at bay for a full 24 hours or more. But that same long half-life means it lingers in the body and stays detectable in urine for a relatively extended period. For most people on a regular daily dose, methadone and EDDP remain detectable in urine for roughly two to four days after the last dose, though the wide range in half-life across individuals (as noted earlier, from about 20 hours with acidic urine to over 40 hours with alkaline urine) means this window can vary substantially.⁴

People who have been on high doses for a long time may take even longer to clear the drug entirely, because methadone accumulates in tissues and releases slowly. A person who stops taking methadone cold turkey after years of maintenance therapy could potentially test positive for longer than someone who took a single dose. Hydration level matters too, not because it speeds up elimination, but because dilute urine lowers the concentration of methadone per milliliter, which can push an otherwise positive result below the cutoff. Testing programs sometimes check for creatinine concentration as a proxy for dilution to catch this.